Say hello to your new platform. 


We're looking forward to hearing from you. Use the form to the right to submit questions and inquiries about potential partnerships along with any comments. 

For press inquiries, please email

We are excited to partner with top companies, universities, and institutions in biomarker development who are looking to leverage our CRISPR-based platform to develop and/or commercialize their indications, from cancer and infectious disease to agriculture and industry. 

Mammoth offers the platform that is: 

  • Affordable

  • Rapid

  • Easy to use

  • Programmable

  • Multiplex capable

  • Reliable